RETRO-PROSPECTIVE POSTMARKET CLINICAL STUDY FOR FX SHOULDER SOLUTIONS SHOULDER SYSTEMS
2 other identifiers
observational
1,004
2 countries
22
Brief Summary
This study takes place in the framework of the PostMarket Clinical Follow-up plan of the Shoulder Systems commercialized by FX SHOULDER SOLUTIONS. The included cases will be followed for 10 years after index surgery. Primary objective is the assessment in real life of the revision rate of the shoulder systems at long-term. Secondary objectives are
- Revision rate at each post op visit
- Range of motion at each post op visit
- Quick Dash, Constant, American Shoulder and Elbow Surgeons Shoulder Score (ASES), Subjective Shoulder Value (SSV), Pain scores at each post op visit
- Radiological assessment of implant positioning through geometrical parameters at each post op visit
- Incidence of complications at each post op visit
- Qualitative feedback from surgeons on the instrumentation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
Longer than P75 for all trials
22 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2020
CompletedFirst Submitted
Initial submission to the registry
April 24, 2026
CompletedFirst Posted
Study publicly available on registry
April 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2036
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2037
April 30, 2026
April 1, 2026
16.6 years
April 24, 2026
April 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Revision rate (KM) at 10 years postoperative
at the end of the postoperative follow-up period of 10 years
Secondary Outcomes (10)
Revision rate (KM) at each post-operative visits
At each postoperative visit (6 weeks, 3 or 6 months, 1 year, 2 years, 3 years, 5 years, 7 years)
Range of Motions at each postoperative visit
At each postoperative visit (6 weeks, 3 or 6 months, 1 year, 2 years, 3 years, 5 years, 7 years, 10 years)
QuickDASH score at each follow-up visit
At each postoperative visit (6 weeks, 3 or 6 months, 1 year, 2 years, 3 years, 5 years, 7 years, 10 years)
Constant-Murley score at each follow-up visit
At each postoperative visit (6 weeks, 3 or 6 months, 1 year, 2 years, 3 years, 5 years, 7 years, 10 years)
ASES score at each postoperative visit
At each postoperative visit (6 weeks, 3 or 6 months, 1 year, 2 years, 3 years, 5 years, 7 years, 10 years)
- +5 more secondary outcomes
Study Arms (11)
Group 1: HUMELOCK II® TSA
Subjects treated with HUMELOCK II® Anatomic Shoulder System
Group 21: cementless HUMELOCK II® RSA - trauma
Subjects treated with cementless HUMELOCK II® Reversible Shoulder System for traumatic indications
Group 22: cemented long HUMELOCK II® RSA - revision
Subjects treated with cemented long HUMELOCK II® Reversible Shoulder System for revision indications
Group 31: SHUMELOCK REVERSED® - degenerative
Subjects treated with HUMELOCK REVERSED® Shoulder System for degenerative indications
Group 32: HUMELOCK REVERSED® - trauma
Subjects treated with HUMELOCK REVERSED® Shoulder System for traumatic indications
Group 4: cementless HUMERIS® Anatomic - degenerative
Subjects treated with cementless HUMERIS® Anatomic Shoulder System for degenerative indications
Group 5: cementless HUMERIS® RSA - degenerative
Subjects treated with cementless HUMERIS® Reversible Shoulder System for degenerative indications
Group 6: EASYTECH® TSA - degenerative
Subjects treated with EASYTECH® Anatomic Shoulder System for degenerative indications
Group 7: EASYTECH® RSA - revision
Subjects treated with EASYTECH® Reversible Shoulder System for revision indications
Group 8: EASYTECH® RSA - degenerative
Subjects treated with EASYTECH® Reversed Shoulder System for degenerative indications
Group 33: HUMELOCK REVERSED® - revision
Subjects treated with HUMELOCK REVERSED® Shoulder System for revision indications
Interventions
Total anatomical (TSA), hemi anatomical (HSA) or reversed (RSA) shoulder arthroplasties.
Eligibility Criteria
Study population is issued from investigators' patient population.
You may qualify if:
- Indication for hemi or total shoulder replacement with one of the FX SHOULDER SOLUTIONS Shoulder Systems, according to its IFU and surgical technique.
- Patient aged 18 years and above
- Patient insured with a social security system
- Has been informed and did consent to participate to the study.
You may not qualify if:
- Neurological pathologies compromising the shoulder stability
- Morbid obesity
- Muscular deficiencies impairing the shoulder joint
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- FX Solutionslead
Study Sites (22)
CHU Amiens Picardie
Amiens, 80054, France
CHU d' Angers
Angers, 49933, France
Hôpital Jean Minjoz
Besançon, 25030, France
Clinique Aguiléra
Biarritz, 64200, France
Hôpital privé Saint-Martin
Caen, 14000, France
Infirmerie Protestante
Caluire-et-Cuire, 69300, France
CHMS Chambéry
Chambéry, 73011, France
HÔPITAUX CIVILS de Colmar
Colmar, 68024, France
Hôpital privé Dijon Bourgogne
Dijon, 21000, France
Clinique Saint Charles
La Roche-sur-Yon, 85016, France
Clinique chirurgicale Porte Océane
Les Sables-d'Olonne, 85101, France
Clinique Saint Charles
Lyon, 69001, France
L'hôpital privé du confluent
Nantes, 44277, France
Hopital Bichat
Paris, 75018, France
Clinique des Maussins
Paris, 75020, France
Pavillon de la Mutualite
Pessac, 33608, France
Clinique Saint Michel et Sainte Anne
Quimper, 29000, France
Clinique Mutualiste
Saint-Etienne, 42000, France
Polyclinique de l'Atlantique
Saint-Herblain, 44819, France
C. H. St- Nazaire
Saint-Nazaire, 44606, France
Clinique de l'Orangerie
Strasbourg, 67000, France
Centre Hospitalier Princesse Grace
Monaco, 98000, Monaco
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2026
First Posted
April 30, 2026
Study Start
June 1, 2020
Primary Completion (Estimated)
December 31, 2036
Study Completion (Estimated)
June 1, 2037
Last Updated
April 30, 2026
Record last verified: 2026-04